Robert P. Roche Jr., Executive VP, WW Pharmaceutical Operations at CEPHALON INC (CEPH), sold 9,210 shares at $76.03 ($704K) on 2007-12-12, disclosed to the SEC on 2007-12-14.
Open-market sale of $704k CEPH by Executive VP, WW Pharmaceutical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.49 | 1,273 | $100K | 14.2% |
| 2 | $75.89 | 37 | $3K | 0.4% |
| 3 | $75.90 | 100 | $8K | 1.1% |
| 4 | $75.92 | 400 | $30K | 4.3% |
| 5 | $75.94 | 1,000 | $76K | 10.8% |
| 6 | $75.95 | 500 |
| $38K |
| 5.4% |
| 7 | $75.96 | 100 | $8K | 1.1% |
| 8 | $75.97 | 200 | $15K | 2.2% |
| 9 | $75.98 | 200 | $15K | 2.2% |
| 10 | $76.00 | 500 | $38K | 5.4% |
| 11 | $76.01 | 700 | $53K | 7.6% |
| 12 | $76.02 | 200 | $15K | 2.2% |
| 13 | $76.03 | 300 | $23K | 3.2% |
| 14 | $76.05 | 100 | $8K | 1.1% |
| 15 | $76.06 | 600 | $46K | 6.5% |
| 16 | $76.07 | 400 | $30K | 4.3% |
| 17 | $76.11 | 482 | $37K | 5.2% |
| 18 | $76.12 | 100 | $8K | 1.1% |
| 19 | $76.15 | 208 | $16K | 2.3% |
| 20 | $76.16 | 300 | $23K | 3.2% |
| 21 | $76.19 | 100 | $8K | 1.1% |
| 22 | $76.22 | 600 | $46K | 6.5% |
| 23 | $76.29 | 700 | $53K | 7.6% |
| 24 | $76.30 | 10 | $763 | 0.1% |
| 25 | $76.41 | 100 | $8K | 1.1% |
| Total | $76.40 avg | 9,210 | $704K | 100% |
| Filing → |
| ATRS | BUY | 2015-08-17 | $10K | — | Filing → |
| ATRS | BUY | 2014-08-14 | $10K | — | Filing → |
| PATH | BUY | 2011-09-19 | $27K | — | Filing → |